Compounds > naltrexone

naltrexone and propofol

naltrexone has been researched along with propofol in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (26.32)18.2507
2000's8 (42.11)29.6817
2010's6 (31.58)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Chang, TK; Ensom, MH; Kiang, TK1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bartter, T; Gooberman, LL1
Berkowitz, R; Hass, F; Hoffman, WE; McDonald, T1
Collins, PD; Cook, TM1
Berkowitz, R; Cooke, B; Cunningham, F; Hoffman, WE; McDonald, T1
Barelli, A; De Giacomo, M; Gaspari, R; Mannelli, P; Stefanelli, A1
Hensel, M; Kox, WJ; Wolter, S1
Freye, E; Levy, JV; Partecke, L1
Chaudry, S; Daiter, J; Herman, S; Raz, B; Teplin, D; Varenbut, M; Whang, P; Yung, M; Zachos, CT1
Buck, RK; Fosgate, GT; Gerlach, C; Kästner, SBR; Kummrow, M; Meyer, LRC; Stegmann, GF; Zeiler, GE1
Costello, MA; Farrell, AP; Fuller, A; Haw, A; Izwan, A; Maloney, SK; Meyer, LCR; Mitchell, D; Seymour, RS; Snelling, EP1

Reviews

3 review(s) available for naltrexone and propofol

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000
UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Pharmacology & therapeutics, 2005, Volume: 106, Issue:1

    Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic

2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for naltrexone and propofol

ArticleYear
EEG controlled rapid opioid withdrawal under general anaesthesia.
    British journal of anaesthesia, 2000, Volume: 84, Issue:2

    Topics: Anesthesia, General; Anesthetics, Intravenous; Electroencephalography; Female; Humans; Male; Monitoring, Physiologic; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Propofol; Substance Withdrawal Syndrome

2000
Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD)--correlation with neurophysiological parameters--.
    Neurophysiologie clinique = Clinical neurophysiology, 2004, Volume: 34, Issue:2

    Topics: Acetates; Adult; Amines; Anesthesia; Anesthetics, Intravenous; Cyclohexanecarboxylic Acids; Electric Stimulation; Evoked Potentials, Somatosensory; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Heroin Dependence; Hormone Antagonists; Humans; Magnesium; Male; Median Nerve; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Potassium; Propofol; Restless Legs Syndrome; Somatostatin; Substance Withdrawal Syndrome; Water-Electrolyte Balance

2004

Other Studies

14 other study(ies) available for naltrexone and propofol

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Rapid opiate detoxification.
    The American journal of drug and alcohol abuse, 1996, Volume: 22, Issue:4

    Topics: Adult; Anesthetics, Intravenous; Critical Care; Female; Heroin Dependence; Humans; Hypnotics and Sedatives; Length of Stay; Male; Middle Aged; Naloxone; Naltrexone; Narcotic Antagonists; Neuromuscular Nondepolarizing Agents; Propofol; Respiration, Artificial; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Vecuronium Bromide

1996
Ultra-rapid opioid detoxification increases spontaneous ventilation.
    Journal of clinical anesthesia, 1998, Volume: 10, Issue:5

    Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Carbon Dioxide; Evaluation Studies as Topic; Humans; Intubation, Gastrointestinal; Intubation, Intratracheal; Naltrexone; Narcotic Antagonists; Neuromuscular Blockade; Nitrous Oxide; Opioid-Related Disorders; Oxygen Consumption; Propofol; Prospective Studies; Respiration; Tidal Volume; Time Factors

1998
Rapid opioid detoxification under anaesthesia.
    Hospital medicine (London, England : 1998), 1998, Volume: 59, Issue:3

    Topics: Adult; Anesthesia, General; Atracurium; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Agents; Humans; Hypnotics and Sedatives; Male; Midazolam; Naloxone; Naltrexone; Narcotic Antagonists; Nicotinic Antagonists; Octreotide; Opioid-Related Disorders; Propofol

1998
Heart rate variability and plasma catecholamines in patients during opioid detoxification.
    Journal of neurosurgical anesthesiology, 1999, Volume: 11, Issue:3

    Topics: Adult; Analysis of Variance; Anesthetics, Intravenous; Blood Pressure; Electroencephalography; Epinephrine; Female; Heart Rate; Humans; Male; Naltrexone; Narcotic Antagonists; Norepinephrine; Opioid-Related Disorders; Propofol; Signal Processing, Computer-Assisted; Substance Withdrawal Syndrome; Sympathetic Nervous System; Sympathomimetics; Wakefulness

1999
Emergency therapeutical approach simulating ultrarapid opioid detoxification in methadone withdrawal precipitated by erroneous administration of naltrexone.
    European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 1999, Volume: 6, Issue:2

    Topics: Adult; Anesthetics, Intravenous; Emergencies; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Propofol; Substance Withdrawal Syndrome

1999
Measurement of symptom withdrawal severity in a 24-hour period after the anesthesia-assisted rapid opiate detoxification procedure.
    The American journal of drug and alcohol abuse, 2005, Volume: 31, Issue:2

    Topics: Adult; Anesthetics, Intravenous; Clinical Protocols; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Inactivation, Metabolic; Injections, Subcutaneous; Male; Naltrexone; Narcotics; Opioid-Related Disorders; Propofol; Retrospective Studies; Severity of Illness Index; Substance Withdrawal Syndrome; Surveys and Questionnaires

2005
Propofol-medetomidine-ketamine total intravenous anaesthesia in thiafentanil-medetomidine-immobilized impala (Aepyceros melampus).
    Veterinary anaesthesia and analgesia, 2017, Volume: 44, Issue:1

    Topics: Adrenergic alpha-2 Receptor Antagonists; Anesthesia, Intravenous; Anesthetics, Combined; Animals; Antelopes; Female; Fentanyl; Heart Rate; Hypnotics and Sedatives; Imidazoles; Ketamine; Medetomidine; Naltrexone; Narcotic Antagonists; Propofol; Prospective Studies; Respiratory Rate

2017
Ameliorating the adverse cardiorespiratory effects of chemical immobilization by inducing general anaesthesia in sheep and goats: implications for physiological studies of large wild mammals.
    Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology, 2018, Volume: 188, Issue:6

    Topics: Analgesics, Opioid; Anesthesia, General; Anesthetics, Intravenous; Animals; Animals, Wild; Azaperone; Etorphine; Goats; Hemodynamics; Hypnotics and Sedatives; Immobilization; Midazolam; Naltrexone; Narcotic Antagonists; Propofol; Respiration; Sheep

2018